Approvals (Drugs@FDA)

MORPHINE SULFATE

UPSHER SMITH LABS · MORPHINE SULFATE

ANDA202104Generic (ANDA)Prescription
Open FDA's page for this record
Application number
ANDA202104
Sponsor name
UPSHER SMITH LABS
Submissions
  1. Submission type
    SUPPL
    Submission number
    4
    Submission status
    AP
    Submission status date
    20140819
    Submission class code
    REMS
    Submission class code description
    REMS
  2. Submission type
    SUPPL
    Submission number
    2
    Submission status
    AP
    Submission status date
    20140715
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
  3. Submission type
    SUPPL
    Submission number
    29
    Submission status
    AP
    Submission status date
    20260618
    Submission class code
    REMS
    Submission class code description
    REMS
  4. Submission type
    SUPPL
    Submission number
    25
    Submission status
    AP
    Submission status date
    20241031
    Submission class code
    REMS
    Submission class code description
    REMS
  5. Submission type
    SUPPL
    Submission number
    23
    Submission status
    AP
    Submission status date
    20231215
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
  6. Submission type
    SUPPL
    Submission number
    9
    Submission status
    AP
    Submission status date
    20170526
    Submission class code
    REMS
    Submission class code description
    REMS
  7. Submission type
    SUPPL
    Submission number
    7
    Submission status
    AP
    Submission status date
    20160930
    Submission class code
    REMS
    Submission class code description
    REMS
  8. Submission type
    SUPPL
    Submission number
    13
    Submission status
    AP
    Submission status date
    20211215
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
  9. Submission type
    SUPPL
    Submission number
    5
    Submission status
    AP
    Submission status date
    20150626
    Submission class code
    REMS
    Submission class code description
    REMS
  10. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20130603
    Submission class code
    UNKNOWN
    Application docs
    1. ID
      24099
      Title
      REMS
      Url
      http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17
      Date
      20150630
      Type
      Other
  11. Submission type
    SUPPL
    Submission number
    11
    Submission status
    AP
    Submission status date
    20180918
    Submission class code
    REMS
    Submission class code description
    REMS
  12. Submission type
    SUPPL
    Submission number
    26
    Submission status
    AP
    Submission status date
    20251222
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
  13. +4 more not shown
Products
  1. Product number
    007
    Reference drug
    No
    Brand name
    MORPHINE SULFATE
    Reference standard
    Yes
    Dosage form
    CAPSULE, EXTENDED RELEASE
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      MORPHINE SULFATE
      Strength
      100MG
  2. Product number
    005
    Reference drug
    No
    Brand name
    MORPHINE SULFATE
    Reference standard
    No
    Dosage form
    CAPSULE, EXTENDED RELEASE
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      MORPHINE SULFATE
      Strength
      60MG
  3. Product number
    003
    Reference drug
    No
    Brand name
    MORPHINE SULFATE
    Reference standard
    No
    Dosage form
    CAPSULE, EXTENDED RELEASE
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      MORPHINE SULFATE
      Strength
      30MG
  4. Product number
    001
    Reference drug
    No
    Brand name
    MORPHINE SULFATE
    Reference standard
    No
    Dosage form
    CAPSULE, EXTENDED RELEASE
    Route
    ORAL
    Marketing status
    Prescription
    Active ingredients
    1. Name
      MORPHINE SULFATE
      Strength
      10MG
  5. Product number
    006
    Reference drug
    No
    Brand name
    MORPHINE SULFATE
    Reference standard
    No
    Dosage form
    CAPSULE, EXTENDED RELEASE
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      MORPHINE SULFATE
      Strength
      80MG
  6. Product number
    004
    Reference drug
    No
    Brand name
    MORPHINE SULFATE
    Reference standard
    No
    Dosage form
    CAPSULE, EXTENDED RELEASE
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      MORPHINE SULFATE
      Strength
      50MG
  7. Product number
    002
    Reference drug
    No
    Brand name
    MORPHINE SULFATE
    Reference standard
    No
    Dosage form
    CAPSULE, EXTENDED RELEASE
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      MORPHINE SULFATE
      Strength
      20MG
Harmonized identifiers (openFDA)
Application number
ANDA202104
Brand name
MORPHINE SULFATE
Generic name
MORPHINE SULFATE
Manufacturer name
Upsher-Smith Laboratories, LLC
Product NDC
0832-0225, 0832-0226, 0832-0227, 0832-0228, 0832-0229, 0832-0230, 0832-0233
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
MORPHINE SULFATE
RxCUI
892345, 892352, 892494, 892554, 892596, 894801, 894814
SPL ID
3984af25-b79e-1fe0-e063-6394a90ac936
SPL set ID
97948a8f-7d1b-4614-b11d-e944cf56590b
Package NDC
0832-0225-00, 0832-0225-50, 0832-0226-00, 0832-0226-50, 0832-0227-00, 0832-0227-50, 0832-0228-00, 0832-0228-50, 0832-0229-00, 0832-0229-50, 0832-0230-00, 0832-0230-50, 0832-0233-00, 0832-0233-50
UNII
X3P646A2J0
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.